IE 11 is not supported. For an optimal experience visit our site on another browser.

Berkeley Lovelace Jr.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.


Latest from Berkeley Lovelace Jr.

How the 2024 presidential election may threaten health coverage for millions

The outcome of the 2024 elections could jeopardize health insurance for millions, experts warn, even as a record number of people in the U.S. sign up for Obamacare.
12d ago

CDC says it has no plans to ease Covid isolation yet, despite urging from doctors

People who test positive for Covid should still isolate for five days according to the CDC, even though many Americans are already ignoring the policy.
17d ago

Novo Nordisk settles two lawsuits over copycat versions of Ozempic and Wegovy

Novo Nordisk said Friday it settled two lawsuits against two businesses claiming to offer compounded versions of its blockbuster drugs Ozempic and Wegovy.
17d ago

Pharma CEOs grilled by senators over sky-high drug prices

Senators grilled drugmakers over the sky-high cost of drug prices in the United States. Eliquis is thousands of dollars more expensive in the U.S
19d ago

FDA names likely source of lead in contaminated cinnamon applesauce pouches

The lead contamination in the recalled WanaBana applesauce pouches likely came from a single processor in Ecuador run by Carlos Aguilera, the FDA said on Tuesday.
19d ago

‘I’m fed up’: Frustrations grow as ADHD drug shortage continues

Amid ongoing ADHD drug shortages, Adderall supplies have improved, but other brand name and generic medications such as Ritalin are still hard to come by, doctors say.
24d ago

Why are Black men at greater risk for prostate cancer?

Defense Secretary Lloyd Austin apologized this week for not being more transparent about his prostate cancer diagnosis, acknowledging that the news had not only affected him but also shocked many others, “especially in the Black community.”
25d ago

CDC warns that Neptune's Fix — 'gas station heroin' — may contain synthetic pot

The highly addictive and dangerous supplement Neptune’s Fix — also known as gas station heroin — may be contaminated with different types of synthetic pot, chemicals that have been linked to life-threatening effects such as seizures, brain swelling and hallucinations, the Centers for Disease Control and Prevention reported Thursday.
26d ago

Novo Nordisk says more patients can start taking Wegovy after it boosts supply

Novo Nordisk said it boosted the supply of the lowest dose of its weight loss drug Wegovy, which it says will allow more people in the U.S. to get a prescription.
27d ago

Medicare to kick off first drug price negotiations, and it could get heated

The government is set to begin negotiating prices on the 10 costliest prescription drugs covered by Medicare this week, setting the stage for a fierce tug of war between U.S. officials and drugmakers.
33d ago

FDA issues new warning about supplements containing tianeptine

The FDA issued a warning on Wednesday about products sold by Neptune’s Fix, a supplement brand, whose products contain tianeptine, commonly known as gas-station heroin.